By Christy Santhosh Oct 22 (Reuters) - AbbVie said on Thursday its experimental drug significantly reduced inflammatory lumps ...

This late-stage readout comes as companies explore the potential of novel mechanisms of action in HS.

Introduction: Skin diseases also affect the mindI'm so itchy that I can't sleep at night.I'm so self-conscious about my acne that I don't want to face people.My child's eczema won't get better, and ...

AbbVie is eyeing regulatory filings in 2027 for the skin disease drug lutikizumab after clearing multiple endpoints in a late ...

It has saved my time a lot, also my back pain has reduced.It saved me a lot of time. Also, my back pain has decreased.These ...

Symptoms are often mistaken for irritation, thrush or an STI, delaying proper treatment. Campaigners say the taboo around ...

A protein best known for its role in Parkinson’s disease may also help melanoma cells survive. Researchers at Oregon Health & ...

Fatty liver disease often develops without obvious symptoms, so a person’s appearance is not a reliable way to identify it.

Shortly after winning a clearance in the skin disease dermatomyositis, brepocitinib posted results suggesting it might also ...

Friendly A skin biopsy can identify a protein associated with Parkinson’s, but it cannot name the disease by itself. The ...

Key TakeawaysMoonLake shares jumped 18% today after AbbVie reported Phase 3 results for a rival hidradenitis suppurativa drug. AbbVie’s lutikizumab beat placebo by 8 percentage points on its main goal ...

Brepocitinib is on a roll. After winning approval for an autoimmune skin disease, Roivant Sciences subsidiary Priovant’s drug ...